Mind Medicine (MindMed) Inc.

NasdaqGS:MNMD Stok Raporu

Piyasa değeri: US$551.5m

Mind Medicine (MindMed) Yönetim

Yönetim kriter kontrolleri 4/4

Mind Medicine (MindMed) CEO'su Rob Barrow, Jun2021 tarihinde atandı, in görev süresi 3.42 yıldır. in toplam yıllık tazminatı $ 2.14M olup, şirket hissesi ve opsiyonları dahil olmak üzere 27.9% maaş ve 72.1% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.27% ine doğrudan sahiptir ve bu hisseler $ 1.52M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.6 yıl ve 3.1 yıldır.

Anahtar bilgiler

Rob Barrow

İcra Kurulu Başkanı

US$2.1m

Toplam tazminat

CEO maaş yüzdesi27.9%
CEO görev süresi3.4yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi2.6yrs
Yönetim Kurulu ortalama görev süresi3.1yrs

Son yönetim güncellemeleri

Recent updates

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate

Nov 04

Psychedelic Stocks: Focus On Their Cash

Aug 15

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

Jun 05

Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data

Apr 04

Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts

Feb 02

Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

May 23
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely

Feb 07
We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely

MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics

Oct 19

MindMed announces proposed public offering of common shares

Sep 27

MindMed doses first patient in phase 1 trial examining psychedelic MDMA-like substances

Sep 20

MindMed regains compliance with Nasdaq's minimum bid price listing requirement

Sep 14

MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value

Sep 04

Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

Aug 26
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder

Aug 24

MindMed soars 71% as it appears to be following in Bed Bath & Beyond's footsteps

Aug 18

Mind Medicine GAAP EPS of -$0.04 beats by $0.01

Aug 11

Mind Medicine announces 1-for-15 reverse stock split

Aug 04

MindMed: Another Psychedelic Medicine Play Trading At A Potential Discount

Jul 12

CEO Tazminat Analizi

Rob Barrow'un ücretlendirmesi Mind Medicine (MindMed)'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$98m

Jun 30 2024n/an/a

-US$102m

Mar 31 2024n/an/a

-US$125m

Dec 31 2023US$2mUS$599k

-US$96m

Sep 30 2023n/an/a

-US$77m

Jun 30 2023n/an/a

-US$75m

Mar 31 2023n/an/a

-US$63m

Dec 31 2022US$5mUS$672k

-US$57m

Sep 30 2022n/an/a

-US$69m

Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$98m

Dec 31 2021US$12mUS$350k

-US$93m

Tazminat ve Piyasa: Rob 'ın toplam tazminatı ($USD 2.14M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 2.36M ).

Tazminat ve Kazançlar: Rob 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Rob Barrow (35 yo)

3.4yrs

Görev süresi

US$2,143,133

Tazminat

Mr. Robert Barrow, also known as Rob, serves as Chief Executive Officer at Mind Medicine (MindMed) Inc since June 9, 2021 and serves a its Director since December 13, 2021. He served as Chief Development O...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Robert Barrow
CEO & Director3.4yrsUS$2.14m0.27%
$ 1.5m
Daniel Karlin
Chief Medical Officer3.8yrsUS$1.04m0.32%
$ 1.8m
Miriam Wernli
Executive President4.3yrsUS$2.66m0.16%
$ 879.7k
Scott Freeman
Co-Founder & Clinical Advisorno dataUS$501.19kVeri yok
Leonard Latchman
Co-founderno dataVeri yokVeri yok
Carrie Liao
VP & Chief Accounting Officer2yrsVeri yok0.060%
$ 332.9k
Mark Sullivan
Chief Legal Officer & Corporate Secretary1.6yrsVeri yok0.072%
$ 396.4k
Francois Lilienthal
Chief Commercial Officer2.6yrsVeri yokVeri yok
Stephanie Fagan
Chief Corporate Affairs Officerless than a yearVeri yokVeri yok

2.6yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: MNMD 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.6 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Robert Barrow
CEO & Director2.9yrsUS$2.14m0.27%
$ 1.5m
Carol Vallone
Independent Chairperson3.2yrsUS$196.20k0.018%
$ 98.7k
David Gryska
Independent Director1.4yrsUS$179.01k0.011%
$ 61.0k
Suzanne Bruhn
Independent Director2.3yrsUS$148.70k0.017%
$ 92.0k
Robert Malenka
Chair of Scientific Advisory Board3.7yrsVeri yokVeri yok
Robert Dworkin
Member of Scientific Advisory Board3.3yrsVeri yokVeri yok
Maurizio Fava
Member of Scientific Advisory Board3.4yrsVeri yokVeri yok
Andreas Krebs
Independent Vice Chairman3.2yrsUS$186.20k0.016%
$ 87.9k
Roger Crystal
Independent Director2.3yrsUS$148.70k0.017%
$ 92.0k
Nzinga Harrison
Member of Scientific Advisory Boardless than a yearVeri yokVeri yok
Peter Bergethon
Member of Scientific Advisory Board3.4yrsVeri yokVeri yok
Maria Oquendo
Member of Scientific Advisory Board3yrsVeri yokVeri yok

3.1yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MNMD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.1 yıldır).